Result? Today we have a problem related to under-treatment: according to research carried out in 2020, just before the Covid-19 pandemic exploded, about 30% of patients eligible for therapy with biological or biosimilar drugs were without treatment. This is due to the imposition by some Regions, especially in those where there is a greater penetration of the biosimilar drug, which alarmed the doctor who feared losing prescribing freedom β. βThe patient who did not know biosimilar drugs β continues Celano β thought that they were not safe drugs. I repeat, there was a lack of correct information, particularly when patients saw themselves changing the drug, with the transition from biologic to biosimilar. Everything passes through communication and everything passes through the trust you have in your doctor.
0 Comments
Leave a Reply. |